Free Trial

TrueBlue (NYSE:TBI) Shares Cross Above 200 Day Moving Average - Time to Sell?

TrueBlue logo with Business Services background

Shares of TrueBlue, Inc. (NYSE:TBI - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $6.28 and traded as high as $6.69. TrueBlue shares last traded at $6.65, with a volume of 60,429 shares traded.

TrueBlue Stock Performance

The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.19. The business has a 50 day simple moving average of $5.91 and a two-hundred day simple moving average of $6.24. The firm has a market cap of $200.96 million, a PE ratio of -1.47 and a beta of 1.53.

TrueBlue (NYSE:TBI - Get Free Report) last released its earnings results on Monday, May 5th. The business services provider reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.17). The business had revenue of $370.25 million during the quarter, compared to analysts' expectations of $362.37 million. TrueBlue had a negative return on equity of 8.25% and a negative net margin of 9.02%. As a group, equities research analysts forecast that TrueBlue, Inc. will post 0.15 earnings per share for the current fiscal year.

Institutional Trading of TrueBlue

Institutional investors and hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC raised its holdings in shares of TrueBlue by 217.2% in the first quarter. GAMMA Investing LLC now owns 8,135 shares of the business services provider's stock valued at $43,000 after acquiring an additional 5,570 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of TrueBlue in the first quarter valued at about $86,000. AE Wealth Management LLC raised its holdings in shares of TrueBlue by 55.2% in the first quarter. AE Wealth Management LLC now owns 19,616 shares of the business services provider's stock valued at $104,000 after acquiring an additional 6,973 shares in the last quarter. Proficio Capital Partners LLC bought a new stake in shares of TrueBlue in the fourth quarter valued at about $116,000. Finally, MetLife Investment Management LLC raised its holdings in shares of TrueBlue by 23.5% in the fourth quarter. MetLife Investment Management LLC now owns 15,886 shares of the business services provider's stock valued at $133,000 after acquiring an additional 3,028 shares in the last quarter. 97.15% of the stock is currently owned by institutional investors.

About TrueBlue

(Get Free Report)

TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.

Further Reading

Should You Invest $1,000 in TrueBlue Right Now?

Before you consider TrueBlue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.

While TrueBlue currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines